Home▸Erectile Dysfunction Pharmacology▸Intracavernosal Injection Therapy Simulator

💊 Intracavernosal Injection Therapy Simulator

This simulation provides an in-depth look at intracavernosal injection therapy for erectile dysfunction. It covers the process of administering medication directly into the penile tissue to induce and maintain an erection, as well as potential side effects and patient management strategies.

Erectile Dysfunction Pharmacology2DModerate60 FPS
intracavernosal-injection-therapy-simulator ↗ Open standalone

Baseline Flaccid State

Cavernosal muscle stays tonically contracted until a signal arrives.

  • Contracted: Resting muscle tone (sympathetic dominance)
  • Low: Sinusoidal blood volume (collapsed spaces)
  • ~2-5 mL/min: Arterial inflow (baseline trickle)
  • Unrestricted: Venous outflow (open drainage)

Resting smooth muscle tone

Cavernosal muscle stays contracted by default, day and night.

The normal nerve pathway

Arousal usually signals via pelvic nerves releasing nitric oxide.

Why this pathway can fail

Nerve damage, vascular disease, or psychogenic causes can block it.

Injection Administered

A fine needle delivers alprostadil directly into erectile tissue.

  • Corpus cavernosum: Injection site (lateral proximal shaft)
  • 27-30G: Typical needle gauge (insulin-syringe scale)
  • 5-20 min: Onset of action (dose dependent)
  • PGE1 analog: Drug class (alprostadil)

Where the needle goes

Injected into the lateral corpus cavernosum, away from vessels and nerves.

Why intracavernosal, not oral

Local delivery skips gut absorption and systemic dilution entirely.

Dose titration

Clinicians start low and adjust to avoid prolonged erections.

Direct Smooth Muscle Relaxation

Alprostadil relaxes muscle locally, no nerve signal required at all.

  • EP receptors: Receptor target (prostaglandin E1)
  • cAMP ↑: Second messenger (via adenylate cyclase)
  • NO / cGMP: Bypassed pathway (nerve-dependent route)
  • 5-20 min: Onset window (to full relaxation)

The cAMP pathway

PGE1 binds EP receptors, raising cAMP and relaxing muscle fibers.

Skipping nitric oxide entirely

This route works even when nerves cannot release nitric oxide.

Why this suits neurogenic ED

Spinal injury or prostatectomy patients often keep this pathway intact.

Rapid Arterial Inflow

Relaxed sinusoidal spaces open and flood rapidly with blood.

  • 20-40×: Inflow surge (over resting baseline)
  • Rapid: Sinusoid expansion (seconds to minutes)
  • Rising: Cavernosal pressure (toward systolic level)
  • 5-15 min: Time to rigidity (typical response)

Sinusoidal filling

Relaxed trabecular spaces expand and rapidly fill with arterial blood.

Pressure builds toward rigidity

Cavernosal pressure climbs as inflow far outpaces outflow.

Compression begins

Expanding sinusoids start pressing against the tunica albuginea.

Sustained Erection

Compressed veins trap blood, sustaining rigidity for thirty to sixty minutes.

  • 30-60 min: Typical duration (dose dependent)
  • Subtunical veins compressed: Veno-occlusion (traps inflow)
  • Low-dose protocol: Priapism risk (reduces overdose risk)
  • Gradual: Detumescence (as drug effect wanes)

The venous trap

Swollen sinusoids compress subtunical veins, locking blood inside.

Duration depends on dose

Higher alprostadil doses extend rigidity but raise priapism risk.

Return to baseline

As the drug clears, muscle tone returns and outflow reopens.

⚙ Under the hood

This simulation provides an in-depth look at intracavernosal injection therapy for erectile dysfunction. It covers the process of administering medication directly into the penile tissue to induce and maintain an erection, as well as potential side effects and patient management strategies.

CanvasBiomedicine

2D · HTML5 Canvas 2D · 60 FPS target · runs fully client-side, no install

What did you find?

Add reproduction steps (optional)